Photo from wikipedia
With increased opioid use, drug‐drug interactions (DDIs) and associated adverse events are growing among geriatric patients. However, the clinical significance of potential metabolic DDIs associated with opioid use has not… Click to show full abstract
With increased opioid use, drug‐drug interactions (DDIs) and associated adverse events are growing among geriatric patients. However, the clinical significance of potential metabolic DDIs associated with opioid use has not been fully evaluated among geriatric patients. Particularly, cytochrome (CYP) P450 enzymes are important in drug metabolism of oxycodone and a black box warning for oxycodone reveals serious risks associated with drug‐oxycodone interactions. This study focused on the use of oxycodone in geriatric patients to evaluate its adverse drug reactions (ADRs) and DDIs associated with CYP P450 enzymes.
Journal Title: Journal of Clinical Pharmacy and Therapeutics
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!